Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin

• Main Authors: Lin Zhang (Author), Ling Li (Author), Xia Wang (Author), Huimin Liu (Author), Yibin Zhang (Author), Tiantian Xie (Author), Hui Zhang (Author), Xiaodong Li (Author), Tianhuan Peng (Author), Xing Sun (Author), Jing Dai (Author), Jing Liu (Author), Wencan Wu (Author), Mao Ye (Author), Weihong Tan (Author)
• Format: Book
• Published: Elsevier, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

PROteolysis TArgeting Chimeras (PROTACs) induce targeted protein degradation by hijacking the intracellular ubiquitin proteasome system, thus emerging as a new strategy for drug development. However, most PROTACs generated lack cell-type selectivity and are poorly soluble in water. To address this d...